Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 228,070 shares at $29.85 ($6.9M) on 2023-02-03, disclosed to the SEC on 2023-02-07.
Open-market sale of $6.9M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.85 | 6,318 | $189K | 2.7% |
| 2 | $29.85 | 6,318 | $189K | 2.7% |
| 3 | $30.46 | 62,468 | $1.9M | 27.6% |
| 4 | $30.46 | 62,468 | $1.9M | 27.6% |
| 5 | $29.84 | 30,497 | $910K | 13.2% |
| 6 | $29.84 | 30,497 |
| $910K |
| 13.2% |
| 7 | $30.09 | 14,752 | $444K | 6.4% |
| 8 | $30.09 | 14,752 | $444K | 6.4% |
| Total | $30.21 avg | 228,070 | $6.9M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |